Pfizer Nixes Pharmacists' Claims In Lipitor Pay-To-Delay Row
Pfizer Inc. and Ranbaxy Laboratories Inc. on Wednesday beat a member suit brought by a group of nine pharmacists under California law in multidistrict antitrust litigation over Lipitor, with a New...To view the full article, register now.
Already a subscriber? Click here to view full article